Transformation of Streptomyces galilaeus ATCC31 133 with the aklavinone 1 1-hydroxylase gene (dnrF) resulted in the production of many red pigments. The new metabolites were purified and their structures were determined as ll-hydroxylated aclacinomycin A, B and T by spectral analysis. This result indicated that the dnrF was stably expressed in the strain S. galilaeus ATCC 31133 to give rise to hybrid aclacinomycins. In addition, a new aclacinomycin analog named ll-hydroxyaclacinomycin X was isolated from the same culture. Its structure was elucidated as 2//'-amino-l l-hydroxyaclacinomycin Y. It showed strong cytotoxicity against several human tumor cell lines, especially leukemia and melanomacell lines.
Transformation of Streptomyces galilaeus ATCC31 133 with the aklavinone 1 1-hydroxylase gene (dnrF) resulted in the production of many red pigments. The new metabolites were purified and their structures were determined as ll-hydroxylated aclacinomycin A, B and T by spectral analysis. This result indicated that the dnrF was stably expressed in the strain S. galilaeus ATCC 31133 to give rise to hybrid aclacinomycins. In addition, a new aclacinomycin analog named ll-hydroxyaclacinomycin X was isolated from the same culture. Its structure was elucidated as 2//'-amino-l l-hydroxyaclacinomycin Y. It showed strong cytotoxicity against several human tumor cell lines, especially leukemia and melanomacell lines.
The anthracycline antibiotics such as daunorubicin, doxorubicin and aclacinomycin are clinically and commercially important anticancer agents1 '2) . Their cardiotoxic nature limits their dose and long-term use3). This major drawback has led to an intensive search for new members ofanthracycline either by a screening of blocked mutants4~6) or by a hybrid biosynthetic approach7?8). In the course of study on the biosynthesis of doxorubicin, we previously reported the cloning and characterization of the aklavinone ll-hydroxylase gene (dnrF) from doxorubicin-producing Streptomyces peucetius subsp.
caesius ATCC279529). Therefore dnrF should be an ideal probe for the application of hybrid biosynthesis in hosts such as Streptomyces galilaeus ATCC 31133, an aklavinone glycoside producer. Accordingly we transformed S. galilaeus ATCC31 133 with a plasmid pMC213 containing dnrF. Many reddish metabolites were purified from the culture of the transformant and their structures were identified as ll-hydroxyaclacinomycin A (4), llhydroxyaclacinomycin B (2) and 1 1-hydroxyaclacinomycin T (3). In addition, a new anthracyline 3"'-aminoll-hydroxyaclacinomycin Y was isolated and named 1 1-hydroxyaclacinomycin X (1). These results indicated not only that dnrF was stably expressed in S. galilaeus ATCC 31133 to introduce hydroxyl group at C-ll of aglycon but also that the host strain, S. galilaeus ATCC 31 133 produced 2"'-aminoaclacinomycin Y (aclacinomycin X). The present communication describes the purification and structure determination of 1 and other knownanalogs produced by the transformant of S. galilaeus ATCC31 133 transformed with dnrF along with in vitro cytotoxicity of 1 against human tumor panels. 
Materials and Methods Microbial Strain
The aclacinomycin-producing S. galilaeus ATCC 31133 was purchased from the ATCC (Rockville MD, U.S.A.). The plasmid pMC213 which contained the dnrV encoding aklavinone 1 1-hydroxyase was obtained from our previous work9). Protoplast transformations of S. galilaeus ATCC 31133 with the plasmid pMC213 were carried out as described by Hopwoodet al.i0\
The transformants were maintained in R2YE agar medium containing 25 /ig/ml of thiostrepton (Sigma). ZnSO4-7H2O 0.0002% (pH 7.0) was inoculated with 300 ml of the seed culture. The fermentation was carried out at 28°C for 4 days for the isolation of4 and for 7 days for the isolation of 1, 2 and 3. The concentration of thiostrepton in seed and main culture were 25 /xg/ml and lO jUg/ml, respectively.
In Vitro Cytotoxicity
The cytotoxicity results of aclacinomycin antibiotic against human tumor cell line panels were obtained through the cooperation of Dr. V. L. Narayanan at the National Cancer Institute, U.S.A.
Spectroscopic Methods
Melting points were determined without correction on a Electrothermal 9100. UVspectra were recorded on a Milton Roy 3000 spectronic array and IR spectra were measured with a Laser Precision Analytical RFX-65 FT-IR. Optical rotations were determined on a JASCO DIP-1 8 1 polarimeter. FAB-MSspectra were recorded on a JEOL HX-100 Spectrometer. The XH and 13C NMR spectra were obtained in CDC13 solution on a Varian Unity 300 or 500 spectrometer. Chemical shifts are expressed in 3 value with TMSas an internal reference and coupling constants (/) are given in Hz.
Results and Discussion Isolation and Purification 1 1-Hydroxyaclacinomycins 1, 2, 3 and 4 were purified to microcrystalline powders by the procedure illustrated in Fig. 2 . The culture broth was centrifuged to separate corresponding to the molecular ion and cleavages at the C-V" and C-l" anomeric carbons, respectively. The structure of 1 was elucidated from the XHNMR,13C
NMR,^H COSY,^-^C COSY and HMBC spectral analysis. The XHNMRspectrum of 1 showed four methyl groups in the up field region and five proton signals in the anomeric region (Table 3) . Three signals appeared at 8 5.51, 5.05, and 5.23 were assigned as anomeric protons attached at the C-l', C-l" and C-l'" and one signal at 8 5.20 was determined as the proton at C-7. The chemical shifts of these four protons were similar to those of 1 1-hydroxyaclacinomycin A4'12). In addition, one characteristic sharp singlet integrating for Together with the presence of the extra nitrogen atom revealed by HRFAB-MS spectra, these chemical shifts suggest that the third sugar would have a jS-enamino ketone moiety11}. In fact, the placement of the NH2 group at C-2"' was fully consistent with all the spectral To date, the sugar residues containing an a,jS-unsaturated ketone moiety in the anthracyclines were known as L-aculose and rednose which were found in aclacinomycin Y2) and in rudolphomycin1 1}, respectively.
The UVand XHand 13C NMRspectral data indicated that 1 would have rednose in the sugar residue. The chemical shift assignments of the 13C NMRspectrum of 1 were similar to those of 1 1-hydroxyaclacinomycin A with the exception of the third sugar residue at C-l'", 2'", 3'" and C-4///12). The assignment of the carbons of the sugar residues was made by comparison with the spectral data of rudolphomycin. From all these findings, the structure of this newanthracycline compoundwas determined as 7
which was named 1 1-hydroxyaclacinomycin X. Other 1 1-hydroxy anthracycline compounds, 2, 3, and 4 were also isolated and their structures elucidated. They showed molecular ion peaks at m/z 826 (M+H)+, 586 (M+H)+ APR. 1996 and 828(M + H)+ in the FAB-MSspectrum, respectively. The UVspectra of the compoundsshowed very similar absorption maxima around 234, 254, 292 and 492nm, indicating the presence of another hydroxyl group in the molecule which is causing a bathochromic shift from 430nm to 492 nm (data not shown). XH NMR (Table 2) and 13C NMRspectral analysis (data not shown) further indicated that these compounds were e-rhodomycinone glylcosides, according to the absence of a singlet aromatic proton (H-l l) and the characteristic down field shift of C-ll signal resulting from the hydroxylation at C-ll.
Comparisons of their physico-chemical properties and *H and 13C NMRspectral data with those ofepelmycins indicated that 2 was epelmycin B, 3 was epelmycin D and 4 was epelmycin E, which were previously isolated from the culture broth of a blocked mutant of /3-rhodomycin-producing Streptomyces violaceus A2624).
In Vitro Antitumor Activity (MALME-3M, SK-MEL-2, SK-MEL-5 and UACC-62) and renal cancer (CAKI-1).
These remarkably potent cytotoxicities and the high sensitivity of certain human cancer cells suggest that this compoundshould be further evaluated for future application in cancer chemotherapy.
